Neomend develops and manufactures surgical sealants based on its Progel hydrogel polymer technology, including pleural air-leak and vascular sealants. Bard acquired the Irvine-based company in 2012; FDA manufacturing records continued to identify Neomend in 2025.
| Company Operating Status | Acquired |
|---|---|
| Wellfound ID | neomend |